We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 3,165 results
  1. Long-term, low-dose macrolide antibiotic treatment in pediatric chronic airway diseases

    Abstract

    Macrolide antibiotics are one of the most commonly used broad-spectrum antibiotics. They have an inhibitory effect on a variety of...

    Jialiang Sun, Yanan Li in Pediatric Research
    Article Open access 12 June 2021
  2. Infantile hypertrophic pyloric stenosis: maternal diabetes and perinatal exposure to non-macrolide antibiotics

    Objective

    Infant exposure to macrolide antibiotics is a risk factor for infantile hypertrophic pyloric stenosis (IHPS). The aim of the study was to...

    Shani Cohen Elias, Shaked Yarza, ... Kyla Anna Marks in Journal of Perinatology
    Article 26 January 2023
  3. Efficacy of doxycycline therapy for macrolide-resistant Mycoplasma pneumoniae pneumonia in children at different periods

    Background

    The prevalence of macrolide-resistant Mycoplasma pneumoniae has increased considerably. Treatment in children has become challenging. This...

    Ying Chen, Yan Zhang, ... Hong-Bo Shi in Italian Journal of Pediatrics
    Article Open access 05 March 2024
  4. Use of proton pump inhibitors and macrolide antibiotics and risk of acute kidney injury: a self-controlled case series study

    Background

    Proton pump inhibitors (PPIs) are widely used for the treatment of gastrointestinal disorders such as peptic ulcer disease and dyspepsia....

    Keiko Ikuta, Shunsaku Nakagawa, ... Tomohiro Terada in BMC Nephrology
    Article Open access 30 November 2022
  5. Impact of macrolide treatment on long-term mortality in patients admitted to the ICU due to CAP: a targeted maximum likelihood estimation and survival analysis

    Introduction

    Patients with community-acquired pneumonia (CAP) admitted to the intensive care unit (ICU) have high mortality rates during the acute...

    Luis Felipe Reyes, Esteban Garcia, ... Grant Waterer in Critical Care
    Article Open access 31 May 2023
  6. Cavitatory necrotising pneumonia with extrapulmonary multi-systemic involvement — a rare presentation of macrolide-resistant Mycoplasma pneumoniae

    Background

    Mycoplasma pneumoniae is one of the leading causes of community-acquired pneumonia. Due to its microbiological variation, clinical...

    Namitha Mohan, Vishal Dnyaneshwar Sawant, Alpana Kondekar in The Egyptian Journal of Internal Medicine
    Article Open access 14 March 2023
  7. Variables associated with antibiotic treatment tolerance in patients with Mycobacterium avium complex pulmonary disease

    Background

    Treatment of Mycobacterium avium complex pulmonary disease (MAC-PD) involves prolonged courses of multiple antibiotics that are variably...

    Meghan Marmor, Husham Sharifi, ... Stephen Ruoss in Respiratory Research
    Article Open access 11 March 2024
  8. Early discontinuation of combination antibiotic therapy in severe community-acquired pneumonia: a retrospective cohort study

    Background

    Severe community-acquired pneumonia (SCAP) is commonly treated with an empiric combination therapy, including a macrolide, or a quinolone...

    Pauline Guillot, Flora Delamaire, ... Adel Maamar in BMC Infectious Diseases
    Article Open access 18 September 2023
  9. Molecular beacon based real-time PCR p1 gene genoty**, macrolide resistance mutation detection and clinical characteristics analysis of Mycoplasma pneumoniae infections in children

    Background

    Mycoplasma pneumoniae can be divided into different subtypes on the basis of the sequence differences of adhesive protein P1, but the...

    Lifeng Li, Jiayue Ma, ... Wancun Zhang in BMC Infectious Diseases
    Article Open access 06 September 2022
  10. Quality of antibiotic prescribing for pediatric community-acquired Pneumonia in outpatient care

    Background

    Antibiotics remain the primary treatment for community acquired pneumonia (CAP), however rising rates of antimicrobial resistance may...

    Ariana Saatchi, Manon R. Haverkate, ... Fawziah Marra in BMC Pediatrics
    Article Open access 28 October 2023
  11. Clinical algorithm reduces antibiotic use among children presenting with respiratory symptoms to hospital in central Vietnam

    Objective

    To assess the safety and utility of a pragmatic clinical algorithm to guide rational antibiotic use in children presenting with respiratory...

    Phuong TK Nguyen, Tam TM Nguyen, ... Ben J Marais in Pneumonia
    Article Open access 25 July 2023
  12. Doxycycline vs. macrolides in combination with a β-lactam antibiotic for the treatment of community-acquired pneumonia in inpatients

    Background

    Hospitalized patients with non-severe community-acquired pneumonia (CAP) are treated with a β-lactam plus either a macrolide or...

    Raghad K. Aldhahri, Shahad G. Gabb, ... Abrar K. Thabit in European Journal of Medical Research
    Article Open access 08 December 2022
  13. Evaluation of treatment with two weeks of doxycycline on macrolide-resistant strains of Mycoplasma genitalium: a retrospective observational study

    Background

    Increasing macrolide resistance makes treatment of Mycoplasma genitalium infections challenging. The second-line treatment is...

    M. Gossé, S. A. Nordbø, B. Pukstad in BMC Infectious Diseases
    Article Open access 07 December 2021
  14. Physicians’ irrational attitudes on the antibiotic prescribing for the treatment of COVID-19 in Turkey: A multicenter survey

    Background

    The inappropriate and excessive use of antibiotics during the coronavirus pandemic has become an important issue.

    Objective ...
    Demet Polat Yuluğ, Berker Öztürk, ... Sibel Naycı in BMC Health Services Research
    Article Open access 21 May 2024
  15. Genome analysis of Streptococcus spp. isolates from animals in pre-antibiotic era with respect to antibiotic susceptibility and virulence gene profiles

    Lyophilized Streptococcus spp. isolates ( n = 50) from animal samples submitted to the diagnostic laboratory at the University of Connecticut in the...

    Ji-Yeon Hyeon, Junwon Kim, ... Guillermo R. Risatti in Veterinary Research
    Article Open access 15 April 2024
  16. Antibiotic prescribing for children with upper respiratory tract infection: a Finnish nationwide 7-year observational study

    Upper respiratory tract infection (URTI) is a self-limiting viral infection and should not be treated with antibiotics. The aim was to evaluate...

    Matti Korppi, Paula Heikkilä, ... Péter Csonka in European Journal of Pediatrics
    Article Open access 23 May 2022
  17. How Streptococcus suis escapes antibiotic treatments

    Streptococcus suis is a zoonotic agent that causes sepsis and meningitis in pigs and humans. S. suis infections are responsible for large economic...

    Cristina Uruén, Carla García, ... Jesús Arenas in Veterinary Research
    Article Open access 12 November 2022
  18. Zoonotic and antibiotic-resistant Campylobacter: a view through the One Health lens

    As a pathogen of a major public health concern with animal health importance, Campylobacter constitutes a clear and present threat to One Health....

    Qi**g Zhang, Ashenafi Feyisa Beyi, Yue Yin in One Health Advances
    Article Open access 30 March 2023
  19. Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis

    Background

    Mycoplasma pneumoniae is a common pathogen that causes community-acquired pneumonia in school-age children. Macrolides are considered a...

    Jong Gyun Ahn, Hye-Kyung Cho, ... Ki Hwan Kim in BMC Infectious Diseases
    Article Open access 25 September 2021
  20. Empirical antibiotic treatment for community-acquired pneumonia and accuracy for Legionella pneumophila, Mycoplasma pneumoniae, and Clamydophila pneumoniae: a descriptive cross-sectional study of adult patients in the emergency department

    Background

    Many factors determine empirical antibiotic treatment of community-acquired pneumonia (CAP). We aimed to describe the empirical antibiotic...

    Morten Hjarnø Lorentzen, Flemming Schønning Rosenvinge, ... Helene Skjøt-Arkil in BMC Infectious Diseases
    Article Open access 05 September 2023
Did you find what you were looking for? Share feedback.